Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
Go to our pre-filtered search.
CALML5 interacts with SFN (show SFN Antibodies) in suprabasal epidermis, cocontrols 13% of late differentiation genes, and modulates interaction of SFN (show SFN Antibodies) to some of its binding partners.
CLSP is increased in the upper epidermis in exacerbated atopic dermatitis as compared to non-exacerbated atopic dermatitis and normal skin, revealing a role in re-establishing the epidermal barrier
Ubiquitination of CALML5 in the nucleus is involved in the carcinogenesis of breast cancer in premenopausal women.
CLSP is a physiological heterotrimeric humanin receptor agonist.
An investigation of the cation-binding properties of CLSP and the ensuing conformational changes finds that, with its high- and low-affinity Ca+2 (show CA2 Antibodies)+-binding sites and a pronounced effect of Mg2 (show MUC7 Antibodies)+, CLSP is more similar to troponin C than to calmodulin (show CALM1 Antibodies).
abnormal elevated levels of CLSP, characteristic of psoriatic epidermis, were probably not due to an overexpression of the protein, but most likely the result of its non-degradation
The structure and dynamics of human calmodulin-like skin protein (CLSP) have been characterized by NMR spectroscopy.
This gene encodes a novel calcium binding protein expressed in the epidermis and related to the calmodulin family of calcium binding proteins. Functional studies with recombinant protein demonstrate it does bind calcium and undergoes a conformational change when it does so. Abundant expression is detected only in reconstructed epidermis and is restricted to differentiating keratinocytes. In addition, it can associate with transglutaminase 3, shown to be a key enzyme in the terminal differentiation of keratinocytes.
, calmodulin-like protein 5
, calmodulin-like skin protein